Previous 10 | Next 10 |
Doximity (NYSE: DOCS) was a hot stock when it went public in 2021. Its shares would rise to a value of more than $100 in September of that year before ultimately falling heavily. Today, at around $40 per share, it's nowhere near those highs. However, its valuation was already too ri...
Piper Sandler said that an analysis of downloads of Teladoc Health's ( NYSE: TDOC ) Livongo app indicates that Q2 2022 results for the chronic care business should come in-line. Shares are up ~9% in Thursday afternoon trading. In addition, analyst Jessica Tassan no...
Doximity is the leading professional networking platform for US healthcare professionals. The company has more than 80% of US physicians on its platform. It also offers additional tools and solutions to make day-to-day work easier for doctors. Despite an incredibly profitable ...
With fear and uncertainty rocking the market, many stocks have taken a beating. However, smart investors know that these times are when money is made. High-quality stocks are being sold at depressed prices, and this can lead to some of the best investments to buy and hold for the long term....
It's hard to pick a favorite stock. But if you put a gun to my head, I think I would name Shopify (NYSE: SHOP) , Silvergate Capital (NYSE: SI) , and Doximity (NYSE: DOCS) . All three companies are using the internet to disrupt trillion-dollar markets in retailing...
Doximity's revenue growth rates are slowing. But looking beyond that, there's a lot to like about the business. Doximity oozes free cash flows. Very few businesses report 26% of stock-based compensation adjusted free cash flow. Doximity does. Doximity is a specialized cloud-based ...
The market has become much more conservative in the last few months due to inflation & recession fears. The Pandemic accelerated the transition of Telehealth. Although they are both in Telehealth, Teladoc & Doximity have very different business models. While Teladoc ha...
Shares of healthcare software company Doximity (NYSE: DOCS) took an 11.5% tumble last week. It capped off an atrocious first half of 2022, the worst first half of a year in more than half a century. Through July 1, the S&P 500 was down 19.7%, the Nasdaq Composite was dow...
Stock splits have been getting a lot of attention lately, with several notable companies initiating actions to increase their share counts significantly without changing their valuations. For instance, Amazon finalized a 20-for-1 stock split on June 6 while Shopify finaliz...
A stock that runs up 1,000% can really increase your net worth. Suppose you invest in all three of these healthcare companies, and two of them go belly up. But one of them increases 1,000%. Even though your accuracy is horrible (you're wrong about 66% of them), that one winner means tha...
News, Short Squeeze, Breakout and More Instantly...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSE: DOCS). On August 8, 2023, the Company disclosed disappointing guidance ...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p...
2024-07-10 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...